Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

 

  • Goldman Sachs initiated coverage on Guidewire Software Inc (NYSE: GWRE) with a Neutral rating. The price target for Guidewire Software is set to $57. Guidewire Software shares gained 0.48 percent to close at $60.27 on Monday.
  • Analysts at Macquarie initiated coverage on Royal Caribbean Cruises Ltd (NYSE: RCL) with an Outperform rating. Royal Caribbean Cruises shares gained 0.54 percent to $74.97 in pre-market trading.
  • Analysts at DA Davidson initiated coverage on Proofpoint Inc (NASDAQ: PFPT) with a Neutral rating. The price target for Proofpoint is set to $80. Proofpoint shares fell 1.82 percent to close at $73.49 on Monday.
  • Analysts at Macquarie initiated coverage of Carnival Corp (NYSE: CCL) with a Neutral rating. Carnival shares gained 0.83 percent to $49.54 in pre-market trading.
  • Analysts at Leerink Swann assumed SAGE Therapeutics Inc (NASDAQ: SAGE) with an Outperform rating. The price target for SAGE Therapeutics is set to $68. SAGE Therapeutics shares declined 0.89 percent to close at $45.64 on Monday.
  • Analysts at Argus Research initiated coverage on United Rentals, Inc. (NYSE: URI) with a Buy rating. The price target for United Rentals is set to $90. United Rentals shares rose 0.56 percent to close at $78.93 on Monday.
  • Rodman & Renshaw initiated coverage on Tecogen Inc (NASDAQ: TGEN) with a Buy rating. The price target for Tecogen is set to $6. Tecogen shares dropped 3.85 percent to close at $4.00 on Monday.
  • Analysts at DA Davidson initiated coverage on HubSpot Inc (NYSE: HUBS) with a Buy rating. The price target for HubSpot is set to $76. HubSpot shares dropped 0.03 percent to close at $57.60 on Monday.
  • Analysts Piper Jaffray initiated coverage on Xencor Inc (NASDAQ: XNCR) with an Overweight rating. Xencor shares gained 0.37 percent to close at $24.58 on Monday.
  • Brean Capital assumed Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) with a Buy rating. The price target for Alexion Pharmaceuticals is set to $221. Alexion Pharmaceuticals shares slipped 0.33 percent to close at $122.14 on Monday.

Latest Ratings for GWRE

DateFirmActionFromTo
Jun 2020Wells FargoMaintainsUnderweight
Jun 2020NeedhamMaintainsBuy
Apr 2020BairdDowngradesOutperformNeutral

View More Analyst Ratings for GWRE
View the Latest Analyst Ratings

 

Related Articles (RCL + GWRE)

View Comments and Join the Discussion!

Posted-In: Top InitiationsInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SMEDLake StreetInitiates Coverage On10.0
CHWYCleveland ResearchInitiates Coverage On60.0
TECHStephens & Co.Downgrades273.0
EOGWolfe ResearchDowngrades54.0
MURWolfe ResearchDowngrades10.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com